Motif Neurotech Gets FDA IDE To Study Brain Implant In Depression

from TheBrief.Health · host TheBrief.Health

Motif Neurotech’s implantable depression device may expand treatment options through minimally invasive brain stimulation, offering personalized at-home therapy for patients with treatment-resistant depression.

Episode metadata supplied by the publisher feed · Published May 11, 2026

Embed this episode

Attribution link and audio player

NOW PLAYING

Motif Neurotech Gets FDA IDE To Study Brain Implant In Depression

0:00 1:43

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of TheBrief.Health?

This episode is 1 minute long.

When was this TheBrief.Health episode published?

This episode was published on May 11, 2026.

Can I download this TheBrief.Health episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!